Xolair vs Oral Immunotherapy: Different Food Allergy Goals

Compare the everyday decision

The FDA states that Xolair is not emergency treatment and patients must continue avoiding their allergens. FDA-approved peanut OIT has its own age and safety conditions. Other OIT protocols may differ; ask the clinic what evidence and procedures apply to the exact food and patient.

Start with the diagnosis and your goals

Before comparing treatments, confirm which foods have caused a convincing reaction and what testing actually establishes. If a child already eats a food safely, a positive test alone does not mean that food needs treatment. Discuss the practical goal: fewer accidental-reaction worries, a higher threshold for one food, or a manageable plan at school and restaurants. Next, compare the burden: injection visits and possible adverse effects for Xolair, versus supervised dose escalations, daily dosing rules, illness and exercise precautions, and dose-related reactions for OIT. Ask what happens after a missed OIT dose and whether asthma control changes eligibility. Do not attempt home dose increases or food challenges without the program's instruction.

Questions for the treatment visit

Ask how success will be measured, what level of protection is realistic, what activities or foods remain restricted, what the emergency plan is, and what costs your insurance covers. If multiple foods are involved, ask whether a combined approach is being considered and what evidence supports it for your situation. Clinical trials compare strategies, but an individual plan needs specialist judgment. In the NIH-supported OUtMATCH trial of highly sensitive people allergic to multiple foods, more participants assigned to extended omalizumab than to multi-food OIT met a three-food challenge threshold (36% versus 19%). OIT discontinuation from reactions and treatment burden drove much of the difference. Among participants who completed either treatment, the proportion meeting the threshold was similar. This study informs a specific multi-food decision; it does not prove one approach is superior for every patient or every food.

Can I stop carrying epinephrine if treatment works?

No. Continue the emergency plan and prescribed epinephrine unless your allergist gives a different individualized instruction.

Which option is better for every patient?

Neither. The number of foods, age, asthma, treatment burden, risk tolerance, and treatment goals all matter.

Compare what a typical Tuesday looks like

For OIT, ask where and when the daily dose is taken, what exercise or illness precautions apply, what to do after vomiting or a missed dose, and who answers urgent questions. For Xolair, ask how often injections occur, who administers them, and when benefit will be reviewed. In either case, make sure school, travel, restaurant, and emergency plans remain clear. If a child has more than one food allergy, discuss whether treatment of one food changes the family's practical risk enough to justify the effort. A specialist can explain the evidence and uncertainty; the best plan is the one whose safety rules the family can actually follow consistently.